therapeutic 4,974 words KG: growth 2026-03-26
kind:therapeuticsection:therapeuticsstate:published
Contents

Growth Factor Therapies

💊 Therapeutic Info
NameGrowth Factor Therapies
SummaryComprehensive review of growth factor therapies for neurodegenerative diseases including [BDNF](/proteins/bdnf-protein), [GDNF](/proteins/gdnf-protein), [NGF](/proteins/nerve-growth-factor), [CNTF](/proteins/cntf-protein), and [IGF-1](/proteins/igf-1-protein), covering mechanisms, delivery methods,
Key Genes/ProteinsMTOR
Linked Hypotheses1 hypotheses

Knowledge Graph

Related Hypotheses (30)

Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (7)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.46
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.46
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.46

See Also (1)

mTOR Signaling Dysregulation in Progressive Supranuclea
event · KG edge: regulates

Knowledge Graph (1 edges)

MTOR regulates growth